Explore 3 Stock Ideas & Industry Insights Download Free Report

News

National Bankshares Q3 2026: Net Income Rises to $5.49M

National Bankshares, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 12, 2026, reporting third-quarter net income of $5,488 thousand and nine-month results for the period ended September 30, 2026.

Aditi Sarkar | 12 November 2026

Quantum Cyber N.V. Files 10-Q for Quarter Ended Sept 30, 2026

Quantum Cyber N.V. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 12, 2026, covering the fiscal quarter ended September 30, 2026.

Aakashdeep | 12 November 2026

First Capital Q3 2026: Net Income Rises to $14.2M

First Capital, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 12, 2026, reporting nine-month net income attributable to the company of $14,196 thousand, up from $11,488 thousand in the same period of 2025.

Aakashdeep | 12 November 2026

Sunshine Biopharma 2026 Annual Meeting: Five Board Seats and Equity Plan Expansion

Sunshine Biopharma Inc. filed a Definitive Proxy Statement on November 12, 2026, seeking shareholder votes on director elections, auditor ratification, and an expansion of its 2023 Equity Incentive Plan ahead of a virtual annual meeting scheduled for December 29, 2026.

Anjali Anand | 12 November 2026

Willamette Valley Vineyards Q3 2026: Net Loss Widens

Willamette Valley Vineyards, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing a nine-month net loss of $3,005,769 and a third-quarter net loss of $1,050,820.

Aakashdeep | 12 November 2026

Wilco 63 Corp Posts Q3 2026 Net Income of $1.95M

Wilco 63 Corporation filed a Form 10-Q with the SEC on November 12, 2026, reporting unaudited financial results for the quarterly period ended September 30, 2026, its first full quarter following its Initial Public Offering.

Aakashdeep | 12 November 2026

Aethlon Medical Q2 FY2027: Net Loss and $6.49M Cash

Aethlon Medical, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 12, 2026, covering the second fiscal quarter of fiscal year 2027.

Vinay Lochav | 12 November 2026

Fluent Inc. Posts $14.7M Net Loss for Nine Months Ended Sept 2026

Fluent, Inc. filed its quarterly report on Form 10-Q with the SEC on November 12, 2026, covering the three and nine months ended September 30, 2026, disclosing continued operating losses alongside a year-over-year improvement in quarterly revenue.

Aakashdeep | 12 November 2026

Sunshine Biopharma Posts $4.03M Net Loss for Nine Months Ended Sept 2026

Sunshine Biopharma Inc. filed its quarterly report on Form 10-Q with the SEC on November 12, 2026, covering the three and nine months ended September 30, 2026, disclosing continued operating losses alongside growth in cash and total assets compared to December 31, 2025.

Anjali Anand | 12 November 2026

Praetorian Acquisition Q3 2026: $259M Trust, $3.3M Net Income

Praetorian Acquisition Corp. filed its Form 10-Q for the quarter ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 12, 2026, reporting results for a blank-check company that completed its initial public offering earlier in the year.

Aakashdeep | 12 November 2026
Support

Hi! How can we help you today?

Loading…